PAVmed (PAVM) Enterprise Value (QoQ) (2015 - 2025)
PAVmed (PAVM) Enterprise Value (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42% |
| Sep 30, 2025 | 70.67% |
| Jun 30, 2025 | -404.01% |
| Mar 31, 2025 | -50.46% |
| Jun 30, 2024 | 31.47% |
| Mar 31, 2024 | 122.81% |
| Dec 31, 2023 | 894.53% |
| Sep 30, 2023 | 115.78% |
| Jun 30, 2023 | 60.53% |
| Mar 31, 2023 | 14.17% |
| Dec 31, 2022 | 48.55% |
| Sep 30, 2022 | 18.70% |
| Jun 30, 2022 | 0.45% |
| Mar 31, 2022 | 22.81% |
| Dec 31, 2021 | -60.93% |
| Sep 30, 2021 | 16.19% |
| Jun 30, 2021 | 13.13% |
| Mar 31, 2021 | -158.81% |
| Dec 31, 2020 | -93.24% |
| Sep 30, 2020 | -18.58% |